MedTrace Logo

Watching Live VIA/VILI Examinations on a Digital Screen May Reduce Patients' Anxiety

NCT02945111 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2016-10-26

No results posted yet for this study

Summary

The purpose of this study is to assess whether the degree of anxiety experienced by women undergoing visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) can be reduced by watching the procedure in real-time on a digital screen.

Conditions

Interventions

BEHAVIORAL

Real-time view

BEHAVIORAL

No visual support

Sponsors & Collaborators

  • Prof. Patrick Petignat

    lead OTHER

Principal Investigators

  • Patrick Petignat, MD · University Hospital, Geneva

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02945111 on ClinicalTrials.gov